LTC4 has also been implicated in promoting blood-brain barrier (BBB) disruption and inducing cerebral edema, and the use of CysLTR2 inhibitor HAMI3379 or specific knockdown of CysLTR2 expression significantly reduces post-ischemic reperfusion induced brain necrosis [14, 93]. This evidence concerns the gene CYSLTR2 and brain edema.